Atrys Health : Iberian Precision Medicine consolidator
Atrys Heath is a Spanish health services provider with relevant presence in Iberia and LatAm. In seven years, it has made 16 acquisitions (assets 23x to € 0.7bn, EBITDA 32x to € 47m PF 2022 ), establishing itself as a consolidator and reaching a sufficient scale to capitalise on the very solid prospects for the precision medicine sector (+12% p.a. 2022-2030). We initiate our coverage with an Outperform rating and a € 6.5 price target. The stock enters our European Nextcap Convict...Atrys Health SA. Atrys Health SA, formerly Europath Biosciences SL, is Spain-based company primarily engaged in the predictive and personalized oncology therapies. It operates under Atrys brand name. Atrys is a clinical and translational research laboratory dedicated to the diagnosis, prognosis and treatment of cancer, including hematologic and solid malignancies. It has four areas of activity: Laboratory, Telemedicine, Radiotherapy, as well as Research and Development (R&D). The Company has its diagnostic laboratories and translational research in Barcelona and Granada, and offices in Madrid, Spain.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.